المؤلفون: Jentzsch, L., Grossart, H., Plewe, S., Schulze-Makuch, D., Goldhammer, T.

المصدر: ISME Communications

وصف الملف: application/pdf

العلاقة: https://gfzpublic.gfz-potsdam.de/pubman/item/item_5025174Test; https://gfzpublic.gfz-potsdam.de/pubman/item/item_5025174_1/component/file_5025176/5025174.pdfTest

الإتاحة: https://doi.org/10.1038/s43705-023-00215-xTest
https://gfzpublic.gfz-potsdam.de/pubman/item/item_5025174Test
https://gfzpublic.gfz-potsdam.de/pubman/item/item_5025174_1/component/file_5025176/5025174.pdfTest

المؤلفون: Rejeski, K., Perez, A., Iacoboni, G., Penack, O., Bücklein, V., Jentzsch, L., Mougiakakos, D., Johnson, G., Arciola, B., Carpio, C., Blumenberg, V., Hoster, E., Bullinger, L., Locke, F.L., von Bergwelt-Baildon, M., Mackensen, A., Bethge, W., Barba, P., Jain, M.D., Subklewe, M.

مصطلحات موضوعية: Cancer Research

وصف الملف: application/pdf

العلاقة: http://edoc.mdc-berlin.de/21645/1/21645oa.pdfTest; The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. Rejeski, K. and Perez, A. and Iacoboni, G. and Penack, O. and Bücklein, V. and Jentzsch, L. and Mougiakakos, D. and Johnson, G. and Arciola, B. and Carpio, C. and Blumenberg, V. and Hoster, E. and Bullinger, L. and Locke, F.L. and von Bergwelt-Baildon, M. and Mackensen, A. and Bethge, W. and Barba, P. and Jain, M.D. and Subklewe, M. Journal for ImmunoTherapy of Cancer 10 (5): e004475. 17 May 2022

الإتاحة: https://doi.org/10.1136/jitc-2021-004475Test
http://edoc.mdc-berlin.de/21645Test/
https://edoc.mdc-berlin.de/21645Test/
http://edoc.mdc-berlin.de/21645/1/21645oa.pdfTest

المؤلفون: Rejeski, K., Perez, A., Sesques, P., Berger, C., Jentzsch, L., Mougiakakos, D., Frölich, L., Ackermann, J., Bücklein, V., Blumenberg, V., Schmidt, C., Jallades, L., Fehse, B., Faul, C., Karschnia, P., Weigert, O., Dreyling, M., Hoster, E., Locke, F., von Bergwelt‐Baildon, M., Mackensen, A., Bethge, W., Ayuk, F., Bachy, E., Salles, G., Jain, M., Subklewe, M.

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.82_2879Test

المؤلفون: Perez, Ariel, Iacoboni García-Calvo, Gloria, Penack, Olaf, Jentzsch, Liv, Carpio Segura, Cecilia Carmen, Barba Suñol, Pere, Rejeski, Kai, Bücklein, Veit

المساهمون: Institut Català de la Salut, Rejeski K Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center, Heidelberg, Germany. Perez A Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida, USA. Blood & Marrow Transplant Program, Miami Cancer Institute, Miami, Florida, USA. Iacoboni G, Carpio C, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma of Barcelona, Bellaterra, Spain. Penack O Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. German Cancer Consortium (DKTK) Berlin Site, and German Cancer Research Center, Heidelberg, Germany. Bücklein V Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. Jentzsch L Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cèl·lules B - Tumors - Tractament, Immunoteràpia, Antígens CD - Immunologia, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, CHEMICALS AND DRUGS::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD::Antigens, CD19, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso, Otros calificadores::Otros calificadores::/terapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::antígenos::antígenos de superficie::antígenos de diferenciación::antígenos CD::antígenos CD19

وصف الملف: application/pdf

العلاقة: Journal for ImmunoTherapy of Cancer;10(5); http://dx.doi.org/10.1136/jitc-2021-004475Test; Rejeski K, Perez A, Iacoboni G, Penack O, Bücklein V, Jentzsch L, et al. The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. J Immunother Cancer. 2022 May;10(5):e004475.; https://hdl.handle.net/11351/8036Test; 000797594100008

الإتاحة: https://doi.org/10.1136/jitc-2021-004475Test
https://hdl.handle.net/11351/8036Test

المؤلفون: Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Bethge, Pere Barba, Michael D Jain, Marion Subklewe

المساهمون: Institut Català de la Salut, [Rejeski K] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK) Munich Site, and German Cancer Research Center, Heidelberg, Germany. [Perez A] Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida, USA. Blood & Marrow Transplant Program, Miami Cancer Institute, Miami, Florida, USA. [Iacoboni G, Carpio C, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma of Barcelona, Bellaterra, Spain. [Penack O] Department of Hematology, Oncology and Tumorimmunology, Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. German Cancer Consortium (DKTK) Berlin Site, and German Cancer Research Center, Heidelberg, Germany. [Bücklein V] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. [Jentzsch L] Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cancer Research, Antígens CD - Immunologia, Antigens, CD19, Immunology, Immunoteràpia, Cèl·lules B - Tumors - Tractament, factores biológicos::antígenos::antígenos de superficie::antígenos de diferenciación::antígenos CD::antígenos CD19 [COMPUESTOS QUÍMICOS Y DROGAS], Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Immunotherapy, Adoptive, terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso [ENFERMEDADES], Humans, Immunology and Allergy, ddc:610, Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD::Antigens, CD19 [CHEMICALS AND DRUGS], Otros calificadores::/terapia [Otros calificadores], Retrospective Studies, Pharmacology, Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse [DISEASES], Receptors, Chimeric Antigen, Other subheadings::/therapy [Other subheadings], Oncology, Disease Progression, Molecular Medicine, Lymphoma, Large B-Cell, Diffuse, Neoplasm Recurrence, Local

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e22e70fe13266af2882e4ccd66387986Test
https://doi.org/10.1136/jitc-2021-004475Test